|
May 26, 2021
|
Neoleukin Therapeutics to Participate in Jefferies Virtual Healthcare Conference
|
|
|
May 12, 2021
|
Neoleukin Therapeutics Announces First Quarter 2021 Financial Results and Corporate Update
|
|
|
May 5, 2021
|
Neoleukin Therapeutics Announces Initiation of Phase 1 NL-201 Trial
|
|
|
May 4, 2021
|
Neoleukin Therapeutics to Participate in BofA Securities 2021 Healthcare Conference
|
|
|
May 3, 2021
|
Neoleukin Therapeutics Announces Appointment of Priti Patel, M.D., M.S., as Chief Medical Officer
|
|
|
April 26, 2021
|
Neoleukin Therapeutics Announces Clearance to Proceed with NL-201 Phase 1 Clinical Trial in the United States
|
|
|
March 25, 2021
|
Neoleukin Therapeutics Announces Year End 2020 Financial Results
|
|
|
March 18, 2021
|
Neoleukin Therapeutics to Host 2020 Financial Results Conference Call and Webcast on March 25, 2021
|
|
|
March 2, 2021
|
Neoleukin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
|
|
|
February 5, 2021
|
Neoleukin Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days
|
|
